Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients
03 medical and health sciences
0302 clinical medicine
DOI:
10.1016/j.ymgme.2020.12.127
Publication Date:
2021-02-01T16:14:15Z
AUTHORS (25)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....